Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Angiolillo DJ et al. - Aspirin and clopidogrel, used either solely or in combination, are associated with improved clinical outcomes in high-risk patients, diabetics patients treated with antiplatelet agents remain at higher risk of recurrent ischemic events. In this chapter the efficacy of currently available oral antiplatelet agents in preventing ischemic events is reviewed. In addition, the antiplatelet ‘resistance’ phenomenon in the diabetic population and its impact on clinical outcomes is summarized. Finally, future developments in the field directed towards individualized treatment strategies and novel antiplatelet agents are examined.

Related Articles

A Comparison of Clopidogrel Responsiveness in Patients With Versus Without Chronic Renal Failure
The American Journal of Cardiology, 10/28/09    Relevance Score: 89%

Comparison of Bleeding Complications With Omega-3 Fatty Acids + Aspirin + Clopidogrel—Versus—Aspirin + Clopidogrel in Patients With Cardiovascular Disease
The American Journal of Cardiology, 10/13/09    Relevance Score: 89%

Pharmacogenetic Testing for Clopidogrel Using the Rapid INFINITI Analyzer
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 11/20/09    Relevance Score: 88%

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Vascular Health and Risk Management, 10/22/09    Relevance Score: 87%

Effects of clopidogrel on aspirin specific pathways of platelet inhibition
Platelets, 10/02/09    Relevance Score: 87%

Today in Pharmacology/kinetics...keeping you current

Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia
Lipids in Health and Disease, 12/18/09

New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09

Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
International Journal of Women's Health, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address